[Role of transporters in hepatic drug disposition]
- PMID: 22811997
[Role of transporters in hepatic drug disposition]
Abstract
Liver is regarded as one of the most important organs for drug clearance in the body, which mediates both the metabolism and biliary excretion of drugs. Transporters are a class of functional membrane proteins and control the movement of substances into or out of cells. Transporters, which are extensively expressed in the liver, play important roles in the drug hepatic disposition by regulating the uptake of drugs from blood into hepatocytes or the efflux of drugs and their metabolites into bile. In this review, the localization, functions and substrate selectivity of the major transporters in the liver will be summarized, and the impacts of these transporters on drug hepatic disposition, the potential drug-drug interactions as well as their genetic polymorphisms will also be reviewed.
Similar articles
-
Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.Drug Metab Dispos. 2007 Nov;35(11):2111-8. doi: 10.1124/dmd.107.016162. Epub 2007 Aug 8. Drug Metab Dispos. 2007. PMID: 17686907
-
Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.J Biochem Mol Toxicol. 2014 Mar;28(3):119-28. doi: 10.1002/jbt.21543. Epub 2013 Nov 27. J Biochem Mol Toxicol. 2014. PMID: 24464585
-
Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.J Clin Pharmacol. 2016 Jul;56 Suppl 7:S23-39. doi: 10.1002/jcph.671. J Clin Pharmacol. 2016. PMID: 27385177 Review.
-
Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.Cell Physiol Biochem. 2016;38(5):1815-30. doi: 10.1159/000443120. Epub 2016 May 9. Cell Physiol Biochem. 2016. PMID: 27160211
-
Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):703-29. doi: 10.1517/17425250902976854. Expert Opin Drug Metab Toxicol. 2009. PMID: 19442037 Review.